Whole-body (18)F-FDG PET identifies high-risk myeloma.
暂无分享,去创建一个
[1] Terry M Therneau,et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. , 2002, The New England journal of medicine.
[2] Paul J. van Diest,et al. Biologic correlates of 18fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography , 2002 .
[3] W. Oyen,et al. Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] Yukiko Arisaka,et al. 18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[5] V. Diehl,et al. Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease. , 2001, Blood.
[6] R. Tucker,et al. Impact of fluorine-18 fluorodeoxyglucose positron emission tomography on patient management: first year's experience in a clinical center. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] P. Dupont,et al. Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods? , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] S. Reske,et al. Grading of tumors and tumorlike lesions of bone: evaluation by FDG PET. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[9] P. Dupont,et al. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] L. Griffeth,et al. PET Emerges as Clinical Oncologic Tool , 1999 .
[11] A. Guermazi,et al. Prognostic value of vertebral lesions detected by magnetic resonance imaging in patients with stage I multiple myeloma , 1999, British journal of haematology.
[12] I. Jinnai,et al. Magnetic resonance imaging patterns in patients with multiple myeloma , 1997, British journal of haematology.
[13] S. Larson,et al. Technetium-99m-MIBI versus fluorine-18-FDG in diffuse multiple myeloma. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[14] B. Maldague,et al. Stage I multiple myeloma: value of MR imaging of the bone marrow in the determination of prognosis. , 1996, Radiology.
[15] Scott T. Grafton,et al. PET and [18F]-FDG in oncology: a clinical update. , 1996, Nuclear medicine and biology.
[16] M. Dimopoulos,et al. Multiple myeloma: MR patterns of response to treatment. , 1994, Radiology.
[17] M. Dimopoulos,et al. Risk of disease progression in asymptomatic multiple myeloma. , 1993, The American journal of medicine.
[18] L G Strauss,et al. The applications of PET in clinical oncology. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[19] R. Bataille,et al. Therapeutic implications of myeloma staging * , 1989, European journal of haematology. Supplementum.
[20] W A Murphy,et al. Bone marrow imaging. , 1988, Radiology.
[21] R. Kyle,et al. Computed tomography in diagnosis and management of multiple myeloma and its variants. , 1985, Archives of internal medicine.
[22] R A McLeod,et al. Multiple myeloma: evaluation by CT. , 1985, Radiology.
[23] V. Devita,et al. Cancer : Principles and Practice of Oncology , 1982 .
[24] F. Singer,et al. Radiographic and radionuclide imaging in multiple myeloma: the role of gallium scintigraphy: concise communication. , 1981, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[25] J. Woolfenden,et al. Comparison of bone scintigraphy and radiography in multiple myeloma. , 1980, Radiology.
[26] S. Salmon,et al. A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival , 1975, Cancer.
[27] O. Cope,et al. Multiple myeloma. , 1948, The New England journal of medicine.